MPO and hematoma: The principal component analysis indicated that many cytokines related to inflammation and activated immune system (myeloperoxidase, Il-6, Il-8 and MCP-1) as well as many angiogenic factors (angiopoetin-2, VEGF-A) were found to be significantly more expressed in hematoma.